TRVI
Trevi Therapeutics Inc
NASDAQ: TRVI · HEALTHCARE · BIOTECHNOLOGY
$13.82
-0.14% today
Updated 2026-04-29
Market cap
$1.96B
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-0.32
Dividend yield
—
52W range
$5 – $16
Volume
1.5M
Trevi Therapeutics Inc (TRVI) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-30.20%
ROA
-20.30%
Debt/equity
0.00x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2016 | $0.00 | $-11.09M | — | — | — |
| 2017 | $0.00 | $-12.86M | — | — | — |
| 2018 | $0.00 | $-20.55M | — | — | — |
| 2019 | $0.00 | $-26.05M | — | — | — |
| 2020 | $0.00 | $-32.76M | — | — | — |
| 2021 | $0.00 | $-33.94M | — | — | — |
| 2022 | $0.00 | $-29.15M | — | — | — |
| 2023 | $0.00 | $-29.07M | — | — | — |
| 2024 | $0.00 | $-47.91M | — | — | — |
| 2025 | $0.00 | $-42.76M | — | — | — |